Patent · US Active

Method for evaluating degradation pathways for pancreatin active pharmaceutical agents

US9677114B1 · kind B1 · utility

0Cited by

2References

11Claims

0Family size

Assignee

SCIENTIFIC PROTEIN LABORATORIES, LLC · US

Inventors

Anisha Akula · Madison, US
Yan Wang · Hunan, CN

Key dates

Filing date	Apr 18, 2013
Grant date	Jun 13, 2017
Priority date	—
Expiry date	Apr 18, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q1/40
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Disclosed is a reverse-phase high-performance liquid chromatography based method for evaluating degradation pathways for panctreatin active pharmaceutical ingredients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.